PROTAC-8（Creighton University）

N/A

Report date: 2023/03/02 14:09:21
NME

Base Information

Drug NamePROTAC-8（Creighton University）
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionCyclin-dependent kinase 2 degraders
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsHearing LossNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCreighton UniversitySt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesCreighton UniversitySt. Jude Children'S Research Hospital
Inactive CompaniesN/A
Active IndicationsHearing LossNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A